Nuclear receptors and epigenetic regulation: opportunities for nutritional targeting and disease prevention.

Posttranslational modifications of histones, alterations in the recruitment and functions of non-histone proteins, DNA methylation, and changes in expression of noncoding RNAs contribute to current models of epigenetic regulation. Nuclear receptors (NRs) are a group of transcription factors that, through ligand-binding, act as sensors to changes in nutritional, environmental, developmental, pathophysiologic, and endocrine conditions and drive adaptive responses via gene regulation. One mechanism through which NRs direct gene expression is the assembly of transcription complexes with cofactors and coregulators that possess chromatin-modifying properties. Chromatin modifications can be transient or become part of the cellular "memory" and contribute to genomic imprinting. Because many food components bind to NRs, they can ultimately influence transcription of genes associated with biologic processes, such as inflammation, proliferation, apoptosis, and hormonal response, and alter the susceptibility to chronic diseases (e.g., cancer, diabetes, obesity). The objective of this review is to highlight how NRs influence epigenetic regulation and the relevance of dietary compound-NR interactions in human nutrition and for disease prevention and treatment. Identifying gene targets of unliganded and bound NRs may assist in the development of epigenetic maps for food components and dietary patterns. Progress in these areas may lead to the formulation of disease-prevention models based on epigenetic control by individual or associations of food ligands of NRs.

[1]  M. Denison,et al.  Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. , 2003, Annual review of pharmacology and toxicology.

[2]  A. Berghold,et al.  Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis , 2012, International journal of cancer.

[3]  S. Fujiwara,et al.  N-Terminal Phosphorylation of HP1α Promotes Its Chromatin Binding , 2011, Molecular and Cellular Biology.

[4]  Marie Sevov,et al.  Resveratrol regulates the expression of LXR-alpha in human macrophages. , 2006, Biochemical and biophysical research communications.

[5]  M. Medvedovic,et al.  Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. , 2008, Endocrinology.

[6]  Johan Auwerx,et al.  Nuclear receptors and the control of metabolism. , 2003, Annual review of physiology.

[7]  Tabitha M. Hardy,et al.  Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer , 2013, Molecular Cancer.

[8]  J. Zempleni,et al.  Biotinylation is a natural, albeit rare, modification of human histones. , 2011, Molecular genetics and metabolism.

[9]  J. Wallace,et al.  Artifactual detection of biotin on histones by streptavidin. , 2008, Analytical biochemistry.

[10]  G. Haegeman,et al.  PPARα blocks glucocorticoid receptor α-mediated transactivation but cooperates with the activated glucocorticoid receptor α for transrepression on NF-κB , 2009, Proceedings of the National Academy of Sciences.

[11]  S. Safe,et al.  Vitamin D-interacting Protein 205 (DRIP205) Coactivation of Estrogen Receptor α (ERα) Involves Multiple Domains of Both Proteins* , 2004, Journal of Biological Chemistry.

[12]  B. M. Forman,et al.  Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response , 2008, Hepatology.

[13]  C. Rosen Revisiting the rosiglitazone story--lessons learned. , 2010, The New England journal of medicine.

[14]  D. Romagnolo,et al.  Targeting of aryl hydrocarbon receptor-mediated activation of cyclooxygenase-2 expression by the indole-3-carbinol metabolite 3,3'-diindolylmethane in breast cancer cells. , 2009, The Journal of nutrition.

[15]  Shuk-Mei Ho,et al.  Epigenetics meets endocrinology. , 2011, Journal of molecular endocrinology.

[16]  Kyung-Chul Choi,et al.  EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity. , 2012, International journal of molecular medicine.

[17]  A. Monaco,et al.  Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism , 1994, Nature.

[18]  T. Archer,et al.  Chromatin-dependent Cooperativity between Site-specific Transcription Factors in Vivo* , 2007, Journal of Biological Chemistry.

[19]  B. Jeffy,et al.  An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription. , 2005, Neoplasia.

[20]  R. Pollenz,et al.  Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes. , 1998, Nucleic acids research.

[21]  A. Bellacosa,et al.  DNA demethylation by TDG. , 2012, Epigenomics.

[22]  G. Firestone,et al.  Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells. , 2011, Carcinogenesis.

[23]  Sung-Joon Lee,et al.  Hepatic Lipid Accumulation Alters Global Histone H3 Lysine 9 and 4 Trimethylation in the Peroxisome Proliferator-Activated Receptor Alpha Network , 2012, PloS one.

[24]  F. Suchy,et al.  Direct methylation of FXR by Set7/9, a lysine methyltransferase, regulates the expression of FXR target genes. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[25]  H. Pijl,et al.  Adipose tissue as an endocrine organ: impact on insulin resistance. , 2003, The Netherlands journal of medicine.

[26]  Yan Jiang,et al.  Phorbol esters enhance 1α,25-dihydroxyvitamin D3-regulated 25-hydroxyvitamin d-24-hydroxylase (CYP24A1) gene expression through ERK-mediated phosphorylation of specific protein 3 (Sp3) in Caco-2 cells , 2012, Molecular and Cellular Endocrinology.

[27]  A. Klein-Szanto,et al.  Thymine DNA Glycosylase Is Essential for Active DNA Demethylation by Linked Deamination-Base Excision Repair , 2011, Cell.

[28]  J. Jost,et al.  Estrogen induces a demethylation at the 5' end region of the chicken vitellogenin gene. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Romagnolo,et al.  Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. , 2010, The Journal of nutrition.

[30]  Sungtae Kim,et al.  1,25‐Dihydroxyvitamin D3 Stimulates Cyclic Vitamin D Receptor/Retinoid X Receptor DNA‐Binding, Co‐activator Recruitment, and Histone Acetylation in Intact Osteoblasts , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  J. Lehmann,et al.  Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Chambon,et al.  Retinoic Acid Receptors Interact Physically and Functionally with the T:G Mismatch-specific Thymine-DNA Glycosylase* , 1998, The Journal of Biological Chemistry.

[33]  R. Newbold,et al.  Uterine adenocarcinoma in mice treated neonatally with genistein. , 2001, Cancer research.

[34]  M. Haussler,et al.  Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. , 2010, The Journal of nutritional biochemistry.

[35]  D. Romagnolo,et al.  Aryl Hydrocarbon Receptor-Mediated Carcinogenesis and Modulation by Dietary Xenobiotic and Natural Ligands , 2010 .

[36]  M. Reitman,et al.  WY14,643, a Peroxisome Proliferator-activated Receptor α (PPARα) Agonist, Improves Hepatic and Muscle Steatosis and Reverses Insulin Resistance in Lipoatrophic A-ZIP/F-1 Mice* , 2002, The Journal of Biological Chemistry.

[37]  Robert T. Taylor,et al.  Role of Epigenetic Mechanisms in Differential Regulation of the Dioxin-Inducible Human CYP1A1 and CYP1B1 Genes , 2010, Molecular Pharmacology.

[38]  S. Safe,et al.  Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. , 1998, Toxicology letters.

[39]  C. Afshari,et al.  Estrogen upregulation of BRCA1 expression with no effect on localization , 1998, Molecular carcinogenesis.

[40]  Hans V. Westerhoff,et al.  RETRACTED: Population-Level Transcription Cycles Derive from Stochastic Timing of Single-Cell Transcription , 2009, Cell.

[41]  Yi Zhang,et al.  TET enzymes, TDG and the dynamics of DNA demethylation , 2013, Nature.

[42]  Zachary Smith,et al.  Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice , 2012, Hepatology.

[43]  H. Nakshatri,et al.  Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements. , 1998, Nucleic acids research.

[44]  Juntian Liu,et al.  Epigenetic regulation of retinoic acid receptor β2 gene in the initiation of breast cancer , 2011, Medical oncology.

[45]  Eric J. Schmidt,et al.  Rediscovering Waddington in the post‐genomic age , 2010, BioEssays : news and reviews in molecular, cellular and developmental biology.

[46]  Peter A. Jones,et al.  A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.

[47]  A. Haslberger,et al.  Epigenetic Control of Estrogen Receptor Expression and Tumor Suppressor Genes Is Modulated by Bioactive Food Compounds , 2010, Annals of Nutrition and Metabolism.

[48]  A. Chabowski,et al.  Altered Peroxisome-Proliferator Activated Receptors Expression in Human Endometrial Cancer , 2012, PPAR research.

[49]  Hao Wu,et al.  Reversing DNA Methylation: Mechanisms, Genomics, and Biological Functions , 2014, Cell.

[50]  Jian‐Kang Zhu Active DNA demethylation mediated by DNA glycosylases. , 2009, Annual review of genetics.

[51]  M. Reitman,et al.  WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha ) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice. , 2002, The Journal of biological chemistry.

[52]  H. Sampath,et al.  Polyunsaturated fatty acid regulation of genes of lipid metabolism. , 2005, Annual review of nutrition.

[53]  D. Romagnolo,et al.  BRCA-1 promoter hypermethylation and silencing induced by the aromatic hydrocarbon receptor-ligand TCDD are prevented by resveratrol in MCF-7 cells. , 2012, The Journal of nutritional biochemistry.

[54]  C. Callaway,et al.  IUGR decreases PPARγ and SETD8 Expression in neonatal rat lung and these effects are ameliorated by maternal DHA supplementation. , 2010, Early human development.

[55]  A. Moschetta,et al.  Deciphering the nuclear bile acid receptor FXR paradigm , 2010, Nuclear receptor signaling.

[56]  H. Nguyen,et al.  Hormone-dependent regulation of BRCA1 in human breast cancer cells. , 1995, Cancer research.

[57]  M. Haussler,et al.  Molecular Mechanisms of Vitamin D Action , 2012, Calcified Tissue International.

[58]  Clay C C Wang,et al.  Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator‐activated receptor γ in hepatic stellate cells for their antifibrotic effect , 2012, Hepatology.

[59]  P. Walsh,et al.  Residues 88–109 of Factor IXa Are Important for Assembly of the Factor X Activating Complex* , 2002, The Journal of Biological Chemistry.

[60]  M. Q. Kemp,et al.  The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen. , 2006, Cancer research.

[61]  A. Hoffmann,et al.  Molecular Determinants of Crosstalk between Nuclear Receptors and Toll-like Receptors , 2005, Cell.

[62]  M. Dawson,et al.  The retinoid X receptors and their ligands. , 2012, Biochimica et biophysica acta.

[63]  Shadan Ali,et al.  Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment. , 2012, American journal of translational research.

[64]  L. Peyrin-Biroulet,et al.  Methyl donor deficiency impairs fatty acid oxidation through PGC-1α hypomethylation and decreased ER-α, ERR-α, and HNF-4α in the rat liver. , 2012, Journal of hepatology.

[65]  H. Inoue,et al.  Recent advances in the study on resveratrol. , 2012, Biological & pharmaceutical bulletin.

[66]  Weihsueh A. Chiu,et al.  A Reexamination of the PPAR-α Activation Mode of Action as a Basis for Assessing Human Cancer Risks of Environmental Contaminants , 2009, Environmental health perspectives.

[67]  K. Tanaka,et al.  Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[68]  Huidong Shi,et al.  Soy Isoflavones Have an Antiestrogenic Effect and Alter Mammary Promoter Hypermethylation in Healthy Premenopausal Women , 2009, Nutrition and cancer.

[69]  P. Chambon,et al.  T:G Mismatch-specific Thymine-DNA Glycosylase Potentiates Transcription of Estrogen-regulated Genes through Direct Interaction with Estrogen Receptor α* , 2003, Journal of Biological Chemistry.

[70]  L. Gudas,et al.  Epigenetic Regulatory Mechanisms Distinguish Retinoic Acid-mediated Transcriptional Responses in Stem Cells and Fibroblasts* , 2010, The Journal of Biological Chemistry.

[71]  D. Leitman,et al.  Estrogen Receptor β-Selective Transcriptional Activity and Recruitment of Coregulators by Phytoestrogens* , 2001, The Journal of Biological Chemistry.

[72]  H. Aburatani,et al.  The Peroxisome Proliferator-Activated Receptor γ/Retinoid X Receptor α Heterodimer Targets the Histone Modification Enzyme PR-Set7/Setd8 Gene and Regulates Adipogenesis through a Positive Feedback Loop , 2009, Molecular and Cellular Biology.

[73]  Boo Shan Tseng,et al.  Dynamic Regulation of Effector Protein Binding to Histone Modifications: The Biology of HP1 Switching , 2006, Cell cycle.

[74]  Myles A Brown,et al.  Agonist and Chemopreventative Ligands Induce Differential Transcriptional Cofactor Recruitment by Aryl Hydrocarbon Receptor , 2003, Molecular and Cellular Biology.

[75]  R. Clarke,et al.  Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. , 1999, Oncology reports.

[76]  Y. Bignon,et al.  Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer? , 2012, Omics : a journal of integrative biology.

[77]  D. Accili,et al.  Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ , 2012, Cell.

[78]  M. Y. Kim,et al.  Isoflavones stimulate estrogen receptor-mediated core histone acetylation. , 2004, Biochemical and biophysical research communications.

[79]  S. Surapureddi,et al.  Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[80]  M. Hamburg,et al.  Regulatory action on rosiglitazone by the U.S. Food and Drug Administration. , 2010, The New England journal of medicine.

[81]  M. Hanson,et al.  Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. , 2005, The Journal of nutrition.

[82]  J. Zempleni,et al.  Biotinylation of histones in human cells , 2001 .

[83]  Neil J. McKenna,et al.  Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators , 2002, Cell.

[84]  Dorothy D. Sears,et al.  Selective modulation of promoter recruitment and transcriptional activity of PPARgamma. , 2007, Biochemical and biophysical research communications.

[85]  J. Jameson,et al.  Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[86]  Yi Sun,et al.  Reversal of Hypermethylation and Reactivation of p16INK4a, RARβ, and MGMT Genes by Genistein and Other Isoflavones from Soy , 2005, Clinical Cancer Research.

[87]  P. Chambon,et al.  Association of CBP/p300 acetylase and thymine DNA glycosylase links DNA repair and transcription. , 2002, Molecular cell.

[88]  G. Blackburn,et al.  Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor‐positive and HER2‐overexpressing human breast cancer cells , 2007, Molecular carcinogenesis.

[89]  C. Glass,et al.  Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. , 2006, Genes & development.

[90]  Y. Jamshidi,et al.  Characterization of the Human PPAR Promoter : Identification of a Functional Nuclear Receptor Response Element , 2002 .

[91]  N. Santanam,et al.  Nutraceuticals as Ligands of PPARγ , 2012, PPAR research.

[92]  A. Moschetta,et al.  Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. , 2008, Cancer research.

[93]  Li-Na Wei Non-canonical activity of retinoic acid in epigenetic control of embryonic stem cell , 2013, Transcription.

[94]  J. Beechem,et al.  Accessory Factors Facilitate the Binding of Glucocorticoid Receptor to the Phosphoenolpyruvate Carboxykinase Gene Promoter* , 2001, The Journal of Biological Chemistry.

[95]  C. Mcintosh,et al.  Adipocyte expression of the glucose-dependent insulinotropic polypeptide receptor involves gene regulation by PPARγ and histone acetylation , 2011, Journal of Lipid Research.

[96]  G. Ning,et al.  DAX1 suppresses FXR transactivity as a novel co-repressor. , 2011, Biochemical and biophysical research communications.

[97]  J. Zempleni,et al.  Holocarboxylase synthetase interacts physically with euchromatic histone-lysine N-methyltransferase, linking histone biotinylation with methylation events. , 2013, The Journal of nutritional biochemistry.

[98]  C. Klinge,et al.  Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. , 2000, Endocrinology.

[99]  W. Wahli,et al.  Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice. , 2009, The Journal of clinical investigation.

[100]  N. Jiang,et al.  Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells. , 2010, Asian journal of andrology.

[101]  L. Machlin Handbook of Vitamins , 1991 .

[102]  Janos Zempleni,et al.  Holocarboxylase synthetase synergizes with methyl CpG binding protein 2 and DNA methyltransferase 1 in the transcriptional repression of long-terminal repeats , 2013, Epigenetics.

[103]  C. Larsson,et al.  Epigenetic regulation of glucose transporter 4 by estrogen receptor β. , 2011, Molecular endocrinology.

[104]  G. Steinberg,et al.  Adipose tissue as an endocrine organ , 2010, Molecular and Cellular Endocrinology.

[105]  S. Sugii,et al.  Epigenetic codes of PPARγ in metabolic disease , 2011, FEBS letters.

[106]  Marie Sevov,et al.  Resveratrol regulates the expression of LXR-α in human macrophages , 2006 .

[107]  J. Zempleni,et al.  Biotinylation of histones in human cells. Effects of cell proliferation. , 2001, European journal of biochemistry.

[108]  T. Grange,et al.  Glucocorticoid‐induced DNA demethylation and gene memory during development , 2001, The EMBO journal.

[109]  Á. Pascual,et al.  Nuclear hormone receptors and gene expression. , 2001, Physiological reviews.

[110]  Peter J. Brown,et al.  Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ , 1997 .

[111]  J. Zierath,et al.  Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. , 2009, Cell metabolism.

[112]  Jesse,et al.  Handbook of Vitamins, Fifth Edition , 2013 .

[113]  Lukas M. von Ziegler,et al.  Early life epigenetic programming and transmission of stress‐induced traits in mammals , 2014, BioEssays : news and reviews in molecular, cellular and developmental biology.

[114]  C. Klinge,et al.  Resveratrol Acts as a Mixed Agonist / Antagonist for Estrogen Receptors a and b * , 2000 .

[115]  Helmut Gernsheim,et al.  W. H. Fox Talbot and the history of photography , 1977 .

[116]  J. Kurebayashi,et al.  Expression Levels of Estrogen Receptor-α, Estrogen Receptor-β, Coactivators, and Corepressors in Breast Cancer , 2000 .

[117]  M. Hanson,et al.  Feeding a protein-restricted diet during pregnancy induces altered epigenetic regulation of peroxisomal proliferator-activated receptor-α in the heart of the offspring , 2010, Journal of Developmental Origins of Health and Disease.

[118]  Jun Qin,et al.  N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. , 2003, Molecular cell.

[119]  V. Jordan,et al.  Selective Estrogen Receptor Modulators and Phytoestrogens , 2008, Planta medica.

[120]  C. Walker,et al.  Environmental Estrogens Differentially Engage the Histone Methyltransferase EZH2 to Increase Risk of Uterine Tumorigenesis , 2012, Molecular Cancer Research.

[121]  S. Murphy,et al.  Folic acid supplementation before and during pregnancy in the Newborn Epigenetics STudy (NEST) , 2011, BMC public health.

[122]  S. Kato,et al.  Retraction: ‘Transrepression by a liganded nuclear receptor via a bHLH activator through co‐regulator switching’ , 2004, The EMBO journal.

[123]  M. Ronis,et al.  Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. , 2009, The Journal of nutrition.

[124]  Jianming Xu,et al.  Tissue- and Nuclear Receptor-Specific Function of the C-Terminal LXXLL Motif of Coactivator NCoA6/AIB3 in Mice , 2007, Molecular and Cellular Biology.

[125]  H. Shibuya,et al.  Retraction: DNA demethylation in hormone-induced transcriptional derepression , 2012, Nature.

[126]  F. Trimarchi,et al.  Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex. , 2011, Molecular endocrinology.

[127]  S. Kato,et al.  Hormonal gene regulation through DNA methylation and demethylation. , 2010, Epigenomics.

[128]  D. O'Gorman,et al.  Acute exercise remodels promoter methylation in human skeletal muscle. , 2012, Cell metabolism.

[129]  G. Borgstahl,et al.  Holocarboxylase synthetase is a chromatin protein and interacts directly with histone H3 to mediate biotinylation of K9 and K18. , 2011, The Journal of nutritional biochemistry.

[130]  H. Moon,et al.  Inhibitory Effect of (−)‐Epigallocatechin‐3‐Gallate on Lipid Accumulation of 3T3‐L1 Cells , 2007, Obesity.

[131]  I. Rusyn,et al.  Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha. , 2007, Mutation research.

[132]  Steven W. Ing,et al.  Impact of conjugated linoleic acid on bone physiology: proposed mechanism involving inhibition of adipogenesis. , 2011, Nutrition reviews.

[133]  J. Katzenellenbogen,et al.  Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor. , 2008, Biochemistry.

[134]  S. Kato,et al.  Transrepressive Function of TLX Requires the Histone Demethylase LSD1 , 2008, Molecular and Cellular Biology.

[135]  T. Willson,et al.  The p300 Acetylase Is Critical for Ligand-activated Farnesoid X Receptor (FXR) Induction of SHP* , 2008, Journal of Biological Chemistry.

[136]  S. Safe,et al.  Vitamin D-interacting protein 205 (DRIP205) coactivation of estrogen receptor alpha (ERalpha) involves multiple domains of both proteins. , 2004, The Journal of biological chemistry.

[137]  C. Carlberg,et al.  Dynamics of nuclear receptor target gene regulation , 2010, Chromosoma.

[138]  D. Moore,et al.  Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor. , 2007, Cancer research.

[139]  Vincent Laudet,et al.  Principles for modulation of the nuclear receptor superfamily , 2004, Nature Reviews Drug Discovery.

[140]  D. Moore,et al.  Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review. , 2005, The Journal of nutritional biochemistry.

[141]  S. Fiorucci,et al.  The Methyl Transferase PRMT1 Functions as Co-Activator of Farnesoid X Receptor (FXR)/9-cis Retinoid X Receptor and Regulates Transcription of FXR Responsive Genes , 2005, Molecular Pharmacology.

[142]  Janos Zempleni,et al.  Biotinylation of histones represses transposable elements in human and mouse cells and cell lines and in Drosophila melanogaster. , 2008, The Journal of nutrition.

[143]  T. Kodadek Faculty Opinions recommendation of Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. , 2004 .

[144]  Robin Holliday,et al.  Epigenetics: A Historical Overview , 2006, Epigenetics.

[145]  T. Grange,et al.  Active cytosine demethylation triggered by a nuclear receptor involves DNA strand breaks. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[146]  Ni Ai,et al.  Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. , 2003, Cancer research.

[147]  A. Bednarek,et al.  Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells. , 2012, The British journal of nutrition.

[148]  Albert Jeltsch,et al.  Cyclical DNA methylation of a transcriptionally active promoter , 2008, Nature.

[149]  J. Gregory,et al.  15 Vitamins, Bioactive Food Compounds, and Histone Modifications , 2013 .

[150]  K. Kristiansen,et al.  Human Multipotent Adipose‐Derived Stem Cells Differentiate into Functional Brown Adipocytes , 2009, Stem cells.

[151]  J. Fleet,et al.  Vitamin D and cancer: a review of molecular mechanisms. , 2012, Biochemical Journal.

[152]  Peter A. Jones,et al.  DNA methylation: The nuts and bolts of repression , 2007, Journal of cellular physiology.

[153]  C. Niehrs Active DNA demethylation and DNA repair. , 2009, Differentiation; research in biological diversity.

[154]  H. Shibuya,et al.  DNA demethylation for hormone-induced transcriptional derepression , 2011, Nature.

[155]  C. Allis,et al.  Translating the Histone Code , 2001, Science.

[156]  C. Glass,et al.  Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. , 2002, Cell.

[157]  P. Lefebvre,et al.  Retinoic Acid Receptors Inhibit AP1 Activation by Regulating Extracellular Signal-Regulated Kinase and CBP Recruitment to an AP1-Responsive Promoter , 2002, Molecular and Cellular Biology.

[158]  Christof Niehrs,et al.  Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation , 2007, Nature.

[159]  Ling Xu,et al.  Genistein demethylates the promoter of CHD5 and inhibits neuroblastoma growth in vivo. , 2012, International journal of molecular medicine.

[160]  J. Flier,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[161]  Feng Wang,et al.  The Histone Modifications Governing TFF1 Transcription Mediated by Estrogen Receptor* , 2011, The Journal of Biological Chemistry.

[162]  Frances M. Sladek,et al.  What are nuclear receptor ligands? , 2011, Molecular and Cellular Endocrinology.

[163]  L. Miele,et al.  EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression , 2013, Vascular cell.

[164]  O. Jänne,et al.  Involvement of Proteasome in the Dynamic Assembly of the Androgen Receptor Transcription Complex* , 2002, The Journal of Biological Chemistry.

[165]  L. Magnani,et al.  Nuclear receptors and chromatin: an inducible couple. , 2014, Journal of molecular endocrinology.

[166]  K. Shiota,et al.  Expression of the peroxisome proliferator activated receptor γ gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes , 2009, BMC Biology.

[167]  R. Roeder,et al.  Roles of histone H3-lysine 4 methyltransferase complexes in NR-mediated gene transcription. , 2009, Progress in molecular biology and translational science.

[168]  Christopher K. Glass,et al.  Exchange of N-CoR Corepressor and Tip60 Coactivator Complexes Links Gene Expression by NF-κB and β-Amyloid Precursor Protein , 2002, Cell.

[169]  Heike Brand,et al.  Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target Promoter , 2003, Cell.

[170]  P. Portincasa,et al.  A Pleiotropic Role for the Orphan Nuclear Receptor Small Heterodimer Partner in Lipid Homeostasis and Metabolic Pathways , 2012, Journal of lipids.

[171]  T. Willson,et al.  Ligand-dependent regulation of the activity of the orphan nuclear receptor, small heterodimer partner (SHP), in the repression of bile acid biosynthetic CYP7A1 and CYP8B1 genes. , 2011, Molecular endocrinology.

[172]  L. Altucci,et al.  Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome , 2010, PloS one.

[173]  Xiaodong Cheng,et al.  Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. , 2008, Molecular cell.

[174]  S. Kato,et al.  Retracted: Transrepression by a liganded nuclear receptor via a bHLH activator through co‐regulator switching , 2004, The EMBO journal.

[175]  C. Tohyama,et al.  Modulation of oestrogen receptor signalling by association with the activated dioxin receptor , 2003, Nature.

[176]  Tabitha M. Hardy,et al.  Epigenetic diet: impact on the epigenome and cancer. , 2011, Epigenomics.

[177]  T. Veenstra,et al.  FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. , 2009, Cell metabolism.

[178]  M. Barton,et al.  Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation , 2013, Proceedings of the National Academy of Sciences.

[179]  C. Glass,et al.  Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. , 1998, Genes & development.